Based on the previous experimental results, we wanted to know whether CRABP2 could affect the metabolism of ovarian cancer cells by regulating the expression of HIF1α, ultimately affecting the sensitivity of tumor cells to chemotherapy drugs. Here, HIF1A is linked to ovarian cancer.